Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co. | -0.72% | 363.00 | 1.1% | $1183.94m | |
| JNJ | Johnson & Johnson | -0.13% | 176.99 | 0.7% | $1095.82m | |
| MRK | Merck & Co., Inc. | 0.04% | 107.50 | 0.7% | $995.24m | |
| PFE | Pfizer Inc. | -0.10% | 49.15 | 0.9% | $980.13m | |
| ABBV | AbbVie, Inc. | -0.25% | 159.21 | 1.9% | $904.50m | |
| BMY | Bristol-Myers Squibb Co. | -0.16% | 79.14 | 1.1% | $749.90m | |
| AZN | AstraZeneca Plc | 0.38% | 66.42 | 1.0% | $361.53m | |
| IDXX | IDEXX Laboratories, Inc. | 0.00% | 411.36 | 3.9% | $222.64m | |
| GSK | GSK Plc | -0.09% | 33.96 | 0.3% | $201.84m | |
| HZNP | Horizon Therapeutics Plc | 0.00% | 78.28 | 5.4% | $201.37m | |
| NVS | Novartis AG | -0.03% | 87.76 | 0.2% | $189.98m | |
| CTLT | Catalent, Inc. | 0.05% | 41.41 | 1.9% | $163.88m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.00% | 212.72 | 8.0% | $159.13m | |
| NVO | Novo Nordisk A/S | 1.11% | 120.16 | 0.1% | $157.35m | |
| SNY | Sanofi | 1.08% | 45.88 | 0.2% | $123.05m |
Company Profile
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.